1. Executive Summary |
2. Global In-vitro Toxicology Market Introduction |
2.1. Global In-vitro Toxicology Market – Taxonomy |
2.2. Global In-vitro Toxicology Market –Definitions |
2.2.1. By Technology |
2.2.2. By Method |
2.2.3. By Application |
3. Global In-vitro Toxicology Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global In-vitro Toxicology Market Dynamic Factors – Impact Analysis |
4. Global In-vitro Toxicology Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 |
4.1. Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global In-vitro Toxicology Market, By Technology, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1. Cell Culture Technology |
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. High Throughput Technology |
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Molecular Imaging |
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. OMICS Technology |
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global In-vitro Toxicology Market Forecast, By Method, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1. Cellular Assay |
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Biochemical Assay |
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. In Silico |
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Ex-vivo |
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7. Global In-vitro Toxicology Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1. Systemic Toxicology |
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Dermal Toxicity |
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Endocrine Disruption |
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Ocular Toxicity |
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global In-vitro Toxicology Market Forecast, By End-user, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1. Pharmaceutical Industry |
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Cosmetics & Household Products |
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Diagnostics |
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Chemicals Industry |
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Food Industry |
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. Global In-vitro Toxicology Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1. North America |
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia-Pacific |
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Latin America |
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Middle East and Africa |
9.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
9.6. Global In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application, End-user and Region, 2022 – 2028 |
10. North America In-vitro ToxicologyMarketAnalysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
10.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Cell Culture Technology |
10.1.2. High Throughput Technology |
10.1.3. Molecular Imaging |
10.1.4. OMICS Technology |
10.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Cellular Assay |
10.2.2. Biochemical Assay |
10.2.3. In Silico |
10.2.4. Ex-vivo |
10.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Systemic Toxicology |
10.3.2. Dermal Toxicity |
10.3.3. Endocrine Disruption |
10.3.4. Ocular Toxicity |
10.3.5. Others |
10.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Pharmaceutical Industry |
10.4.2. Cosmetics & Household Products |
10.4.3. Diagnostics |
10.4.4. Chemicals Industry |
10.4.5. Food Industry |
10.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.5.1. USA |
10.5.2. Canada |
10.6. North America In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country, 2022 – 2028 |
10.7. North America In-vitro Toxicology Market Dynamics – Trends |
11. Europe In-vitro Toxicology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
11.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Cell Culture Technology |
11.1.2. High Throughput Technology |
11.1.3. Molecular Imaging |
11.1.4. OMICS Technology |
11.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Cellular Assay |
11.2.2. Biochemical Assay |
11.2.3. In Silico |
11.2.4. Ex-vivo |
11.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Systemic Toxicology |
11.3.2. Dermal Toxicity |
11.3.3. Endocrine Disruption |
11.3.4. Ocular Toxicity |
11.3.5. Others |
11.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Pharmaceutical Industry |
11.4.2. Cosmetics & Household Products |
11.4.3. Diagnostics |
11.4.4. Chemicals Industry |
11.4.5. Food Industry |
11.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Germany |
11.5.2. UK |
11.5.3. France |
11.5.4. Spain |
11.5.5. Italy |
11.5.6. Russia |
11.5.7. Poland |
11.5.8. Rest of Europe |
11.6. Europe In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country,2022 – 2028 |
11.7. Europe In-vitro Toxicology Market Dynamics – Trends |
12. Asia-Pacific In-vitro Toxicology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
12.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Cell Culture Technology |
12.1.2. High Throughput Technology |
12.1.3. Molecular Imaging |
12.1.4. OMICS Technology |
12.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Cellular Assay |
12.2.2. Biochemical Assay |
12.2.3. In Silico |
12.2.4. Ex-vivo |
12.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Systemic Toxicology |
12.3.2. Dermal Toxicity |
12.3.3. Endocrine Disruption |
12.3.4. Ocular Toxicity |
12.3.5. Others |
12.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Pharmaceutical Industry |
12.4.2. Cosmetics & Household Products |
12.4.3. Diagnostics |
12.4.4. Chemicals Industry |
12.4.5. Food Industry |
12.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Japan |
12.5.2. China |
12.5.3. India |
12.5.4. ASEAN |
12.5.5. Australia & New Zealand |
12.5.6. Rest of Asia-Pacific |
12.6. Asia-Pacific In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country,2022 – 2028 |
12.7. Asia-Pacific In-vitro Toxicology Market Dynamics – Trends |
13. Latin America In-vitro Toxicology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
13.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Cell Culture Technology |
13.1.2. High Throughput Technology |
13.1.3. Molecular Imaging |
13.1.4. OMICS Technology |
13.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Cellular Assay |
13.2.2. Biochemical Assay |
13.2.3. In Silico |
13.2.4. Ex-vivo |
13.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Systemic Toxicology |
13.3.2. Dermal Toxicity |
13.3.3. Endocrine Disruption |
13.3.4. Ocular Toxicity |
13.3.5. Others |
13.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Pharmaceutical Industry |
13.4.2. Cosmetics & Household Products |
13.4.3. Diagnostics |
13.4.4. Chemicals Industry |
13.4.5. Food Industry |
13.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Brazil |
13.5.2. Mexico |
13.5.3. Argentina |
13.5.4. Rest of Latin America |
13.6. Latin America In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country,2022 – 2028 |
13.7. Latin America In-vitro Toxicology Market Dynamics – Trends |
14. Middle East and Africa In-vitro Toxicology Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn) |
14.1. Technology Analysis 2017 – 2021 and Forecast 2022 – 2028by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
14.1.1. Cell Culture Technology |
14.1.2. High Throughput Technology |
14.1.3. Molecular Imaging |
14.1.4. OMICS Technology |
14.2. Method Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Cellular Assay |
14.2.2. Biochemical Assay |
14.2.3. In Silico |
14.2.4. Ex-vivo |
14.3. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Systemic Toxicology |
14.3.2. Dermal Toxicity |
14.3.3. Endocrine Disruption |
14.3.4. Ocular Toxicity |
14.3.5. Others |
14.4. End-user Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Pharmaceutical Industry |
14.4.2. Cosmetics & Household Products |
14.4.3. Diagnostics |
14.4.4. Chemicals Industry |
14.4.5. Food Industry |
14.5. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Gulf Cooperation Council (GCC) Countries |
14.5.2. Israel |
14.5.3. South Africa |
14.5.4. Rest of MEA |
14.6. MEA In-vitro Toxicology Market – Opportunity Analysis Index, By Technology, By Method, By Application and Country,2022 – 2028 |
14.7. MEA In-vitro Toxicology Market Dynamics – Trends |
15. Competition Landscape |
15.1. Strategic Dashboard of Top Market Players |
15.2. Company Profiles (Introduction, Financial Analysis, Method& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
15.2.1. Charles River |
15.2.2. Catalent, Inc. |
15.2.3. Eurofins Scientific |
15.2.4. Quest Diagnostics Incorporated |
15.2.5. Laboratory Corporation of America Holdings |
15.2.6. Evotec |
15.2.7. Creative Bioarray |
15.2.8. Gentronix |
15.2.9. HD Biosciences Co., Ltd. |
15.2.10. MB Research Laboratories |
15.2.11. BioIVT |
15.2.12. SGS SA |
15.2.13. GVK Biosciences Private Limited |
15.2.14. InSphero |
16. Research Methodology |
17. Key Assumptions and Acronyms |
Reviews
There are no reviews yet.